亚太地区人类疫苗佐剂市场预测至 2030 年 - 区域分析 - 按类型（颗粒佐剂、乳剂佐剂、组合佐剂及其他）、应用（流感、肝炎、人乳头瘤病毒 (HPV) 及其他）和最终用户（制药和生物技术公司、CMO 和 CRO 及其他）划分
不断增长的制药业推动亚太地区人用疫苗佐剂市场发展
不断扩张的制药业预计将对佐剂的需求产生积极影响，因为它们可以提高疫苗的有效性和安全性。制药行业对传染病、癌症和自身免疫性疾病的日益关注为开发针对这些特定疾病领域的个性化疫苗和佐剂提供了平台。这为佐剂制造商提供了一个机会，可以开发专门的佐剂来增强对这些疾病疫苗的免疫反应。根据 EFPIA 的数据，2016-2021 年期间，巴西、中国和印度制药业分别增长了 11.7%、6.7% 和 11.8%，而欧盟五大市场和美国市场的平均市场增长率分别为 5.8% 和 5.6%。此外，根据印度品牌资产基金会 (IBEF) 的数据，印度是全球制药业的主要新兴参与者。该国是世界上最大的仿制药贸易国，占全球供应量的近 20%。它供应着全球疫苗需求的约 50%。国内制药业包括 3,000 家制药公司和约 10,500 个制造单位。根据印度政府的官方数据，印度制药业的价值接近 500 亿美元，其中超过 250 亿美元来自出口。印度占全球仿制药出口的约 20%。此外，日本是世界上最大的医药市场之一。根据厚生劳动省 (MHLW) 的年度医药生产统计，2020 年日本处方药和非处方药市场规模为 1070 亿美元。随着行业不断发展和创新，对可支持个性化疫苗开发的佐剂的需求不断增加，推动了亚太地区人用疫苗佐剂市场的显着增长和投资。因此，全球不断发展的制药业可能会在未来几年为亚太地区人用疫苗佐剂市场创造丰厚的增长机会。
亚太地区人用疫苗佐剂市场概况
中国已在医疗保健和制药行业投入巨资，旨在增强国内生产、研发能力。这一战略重点使该国成为亚太地区人用疫苗佐剂市场的关键参与者。此外，中国是世界上人口最稠密的国家之一；目前人口约为 14.1 亿。根据 2020 年 10 月发布的最新全球疾病负担 (GBD) 研究，中国人口易患各种传染病、慢性病和急性病。
传染病患病率的上升预计将推动对疫苗接种的需求。根据 ICO/IARC 2023 年 HPV 和癌症信息中心的报告，中国有 5.824 亿 15 岁及以上的女性面临患 HPV 相关宫颈癌的风险。据估计，中国普通人群中约有 3.8% 的女性在特定时间内感染宫颈 HPV-16/18，69.1% 的浸润性宫颈癌归因于 HPV 16 或 18。因此，患者数量的增加和对治疗疫苗的需求增加也有望推动亚太地区人用疫苗佐剂市场的增长。
亚太地区人类疫苗佐剂市场收入及预测至 2030 年（百万美元）
亚太地区人类疫苗佐剂市场细分
亚太地区人类疫苗佐剂市场分为类型、应用、最终用户和国家。
根据类型，亚太地区人类疫苗佐剂市场分为颗粒佐剂、乳剂佐剂、组合佐剂和其他。颗粒佐剂部分在 2022 年占据最大市场份额。
就应用而言，亚太地区人类疫苗佐剂市场分为流感、肝炎、人乳头瘤病毒 (HPV) 和其他。流感细分市场在 2022 年占据了最大的市场份额。
按最终用户划分，亚太地区人用疫苗佐剂市场细分为制药和生物技术公司、CMO 和 CRO 等。制药和生物技术公司细分市场在 2022 年占据了最大的市场份额。
按国家划分，亚太地区人用疫苗佐剂市场细分为日本、中国、印度、澳大利亚、韩国和亚太地区其他地区。2022 年，中国占据了亚太地区人用疫苗佐剂市场份额的主导地位。
Croda International Plc、CSL Ltd、Dynavax Technologies Corp、Hawaii Biotech Inc、Novartis AG、Novavax Inc、Phibro Animal Health Corp、Seppic SA 和 SPI Pharma Inc 是亚太地区人用疫苗佐剂市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Human Vaccine Adjuvants Market - Key Market Dynamics
4.1 Asia Pacific Human Vaccine Adjuvants Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases
4.2.2 Growing Focus on Immunization Programs
4.3 Market Restraints
4.3.1 Manufacturing Complexities and Regulatory Challenges
4.4 Market Opportunities
4.4.1 Growing Pharmaceutical Industry
4.5 Future Trends
4.5.1 Rising Trend of Personalized Vaccines
4.6 Impact of Drivers and Restraints:
5. Human Vaccine Adjuvants Market - Asia Pacific Market Analysis
5.1 Asia Pacific Human Vaccine Adjuvants Market Revenue (US$ Million), 2020 - 2030
5.2 Asia Pacific Human Vaccine Adjuvants Market Forecast Analysis
6. Asia Pacific Human Vaccine Adjuvants Market Analysis - by Type
6.1 Particulate Adjuvant
6.1.1 Overview
6.1.2 Particulate Adjuvant: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Emulsion Adjuvant
6.2.1 Overview
6.2.2 Emulsion Adjuvant: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Combination Adjuvant
6.3.1 Overview
6.3.2 Combination Adjuvant: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Human Vaccine Adjuvants Market Analysis - by Application
7.1 Influenza
7.1.1 Overview
7.1.2 Influenza: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Hepatitis
7.2.1 Overview
7.2.2 Hepatitis: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Human papilloma virus (HPV)
7.3.1 Overview
7.3.2 Human papilloma virus (HPV): Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Human Vaccine Adjuvants Market Analysis - by End User
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Overview
8.1.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
8.2 CMOs and CROs
8.2.1 Overview
8.2.2 CMOs and CROs: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Human Vaccine Adjuvants Market - Country Analysis
9.1 Asia Pacific
9.1.1 Asia Pacific Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
9.1.1.1 China Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 China Human Vaccine Adjuvants Market Breakdown, by Type
9.1.1.1.2 China Human Vaccine Adjuvants Market Breakdown, by Application
9.1.1.1.3 China Human Vaccine Adjuvants Market Breakdown, by End User
9.1.1.2 Japan Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Japan Human Vaccine Adjuvants Market Breakdown, by Type
9.1.1.2.2 Japan Human Vaccine Adjuvants Market Breakdown, by Application
9.1.1.2.3 Japan Human Vaccine Adjuvants Market Breakdown, by End User
9.1.1.3 India Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 India Human Vaccine Adjuvants Market Breakdown, by Type
9.1.1.3.2 India Human Vaccine Adjuvants Market Breakdown, by Application
9.1.1.3.3 India Human Vaccine Adjuvants Market Breakdown, by End User
9.1.1.4 Australia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Australia Human Vaccine Adjuvants Market Breakdown, by Type
9.1.1.4.2 Australia Human Vaccine Adjuvants Market Breakdown, by Application
9.1.1.4.3 Australia Human Vaccine Adjuvants Market Breakdown, by End User
9.1.1.5 South Korea Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 South Korea Human Vaccine Adjuvants Market Breakdown, by Type
9.1.1.5.2 South Korea Human Vaccine Adjuvants Market Breakdown, by Application
9.1.1.5.3 South Korea Human Vaccine Adjuvants Market Breakdown, by End User
9.1.1.6 Rest of Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.1 Rest of Asia Pacific Human Vaccine Adjuvants Market Breakdown, by Type
9.1.1.6.2 Rest of Asia Pacific Human Vaccine Adjuvants Market Breakdown, by Application
9.1.1.6.3 Rest of Asia Pacific Human Vaccine Adjuvants Market Breakdown, by End User
10. Industry Landscape
10.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Dynavax Technologies Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 CSL Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Seppic SA
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 SPI Pharma Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hawaii Biotech Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Croda International Plc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Novavax Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Phibro Animal Health Corp
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Human Vaccine Adjuvants Market Segmentation
Table 2. Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 4. Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 5. Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 6. China Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 7. China Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 8. China Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Japan Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Japan Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 11. Japan Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. India Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 13. India Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 14. India Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Australia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Australia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 17. Australia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. South Korea Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 19. South Korea Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 20. South Korea Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Rest of Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 22. Rest of Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 23. Rest of Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 24. Recent Growth Strategies in the Human Vaccine Adjuvants Market
Table 25. Glossary of Terms, Human Vaccine Adjuvants Market
List of Figures
Figure 1. Asia Pacific Human Vaccine Adjuvants Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Human Vaccine Adjuvants Market Revenue (US$ Million), 2022 - 2030
Figure 4. Asia Pacific Human Vaccine Adjuvants Market Share (%) - by Type (2022 and 2030)
Figure 5. Particulate Adjuvant: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Emulsion Adjuvant: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Combination Adjuvant: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Human Vaccine Adjuvants Market Share (%) - by Application (2022 and 2030)
Figure 10. Influenza: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Hepatitis: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Human Papilloma Virus (HPV): Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Human Vaccine Adjuvants Market Share (%) - by End User (2022 and 2030)
Figure 15. Pharmaceutical and Biotechnology Companies: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. CMOs and CROs: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Human Vaccine Adjuvants Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)
Figure 19. Asia Pacific Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 20. China Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. Japan Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. India Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)
Figure 23. Australia Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)
Figure 24. South Korea Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. Rest of Asia Pacific Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)
1. Croda International Plc
2. CSL Ltd
3. Dynavax Technologies Corp
4. Hawaii Biotech Inc
5. Novartis AG
6. Novavax Inc
7. Phibro Animal Health Corp
8. Seppic SA
9. SPI Pharma Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific human vaccine adjuvants market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific human vaccine adjuvants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific human vaccine adjuvants market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.